Cytori Therapeutics reported $-3499000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Baxter International BAX:US $ 495M 71M
Cerus CERS:US $ -11126000 3.28M
Cytori Therapeutics CYTX:US $ -3499000 924K
Dr.Reddys Laboratories DRRD:IN 10.66B 6.15B
Genocea Biosciences GNCA:US $ -11.72M 2.83M
Haemonetics HAE:US $ 24.51M 23.12M
Infinity Pharmaceuticals INFI:US $ -10.75M 0.5M
Merrimack Pharmaceuticals MACK:US $ -886000 121K
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Northwest Biotherapeutics NWBO:US -10049000 2.49M
Starpharma Holdings Ltd SPL:AU -9302000 1.13M
Sun Pharmaceuticals SUNP:IN IR 21759.2M 5690.1M
Sunesis Pharmaceuticals SNSS:US $ -14.8M 5.74M
Teva Pharmaceutical TEVA:IT 623M 41M